Wellstat Therapeutics
CompanyUnited StatesFounded 1985
Wellstat Therapeutics develops one asset, in phase 2 (PN2034 in type 2 diabetes). Mostly small molecule; based in the United States, founded in 1985.
- 1
- Asset
- Furthest stage
- Phase 2
- 3
- Trials
- 0
- Signals
Pipeline
1Investigational insulin-sensitizing compound evaluated for improving glycemic control
Phase 2, Small molecule, type 2 diabetes
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Trials3
- Similar companies6